Loading…
Lobbying Spend
—
Filings
77
Firms Hired
1
Active Period
2008–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, H.R. 7667, Food & Drug Amendments of 2022, and H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R.2617
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, H.R. 7667, Food & Drug Amendments of 2022, and H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
Personal Care Products Safety Act
2022 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, H.R. 7667, Food & Drug Amendments of 2022, and H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Increasing Transparency in Generic Drug Applications Act
2022 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, H.R. 7667, Food & Drug Amendments of 2022, and H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: — · Firm income: $50,000
Matched citations: S. 4338
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
Personal Care Products Safety Act
2022 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Increasing Transparency in Generic Drug Applications Act
2022 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: S. 4338
Food and Drug Amendments of 2022
2022 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
Personal Care Products Safety Act
2022 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Increasing Transparency in Generic Drug Applications Act
2022 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act, S. 4338, FDASLA Act of 2022, and H.R. 7667, Food & Drug Amendments of 2022
Client expense: — · Firm income: $50,000
Matched citations: S. 4338
Personal Care Products Safety Act
2022 · first_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Personal Care Products Safety Act
2021 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Personal Care Products Safety Act
2021 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Personal Care Products Safety Act
2021 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including S. 2100, Personal Care Products Safety Act
Client expense: — · Firm income: $50,000
Matched citations: S. 2100
Children’s Product Warning Label Act of 2019
2020 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1816
Cosmetic Safety Enhancement Act of 2019
2020 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5279
Personal Care Products Safety Act
2020 · fourth_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: S. 726
Children’s Product Warning Label Act of 2019
2020 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1816
Cosmetic Safety Enhancement Act of 2019
2020 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5279
Personal Care Products Safety Act
2020 · third_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: S. 726
Children’s Product Warning Label Act of 2019
2020 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1816
Cosmetic Safety Enhancement Act of 2019
2020 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5279
Personal Care Products Safety Act
2020 · second_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: S. 726
Children’s Product Warning Label Act of 2019
2020 · first_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Division B- Over the Counter Monograph Safety, Innovation and Reform provisions of The Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019 (H.R. 269), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1816
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
2020 · first_quarter · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279), Division B- Over the Counter Monograph Safety, Innovation and Reform provisions of The Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019 (H.R. 269), Children's Products Warning Label Act of 2019 (H.R. 1816)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 269
Source: Senate LDA